JP2022546964A5 - - Google Patents

Info

Publication number
JP2022546964A5
JP2022546964A5 JP2022513188A JP2022513188A JP2022546964A5 JP 2022546964 A5 JP2022546964 A5 JP 2022546964A5 JP 2022513188 A JP2022513188 A JP 2022513188A JP 2022513188 A JP2022513188 A JP 2022513188A JP 2022546964 A5 JP2022546964 A5 JP 2022546964A5
Authority
JP
Japan
Prior art keywords
sequence
peptide ligand
pbp
ligand according
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022513188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546964A (ja
Filing date
Publication date
Priority claimed from GBGB1912320.7A external-priority patent/GB201912320D0/en
Application filed filed Critical
Publication of JP2022546964A publication Critical patent/JP2022546964A/ja
Publication of JP2022546964A5 publication Critical patent/JP2022546964A5/ja
Ceased legal-status Critical Current

Links

JP2022513188A 2019-08-28 2020-08-28 Pbp結合二環式ペプチドリガンド Ceased JP2022546964A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1912320.7A GB201912320D0 (en) 2019-08-28 2019-08-28 PBP Binding Bicyclic Peptide Ligands
GB1912320.7 2019-08-28
PCT/GB2020/052058 WO2021038232A1 (en) 2019-08-28 2020-08-28 Pbp binding bicyclic peptide ligands

Publications (2)

Publication Number Publication Date
JP2022546964A JP2022546964A (ja) 2022-11-10
JP2022546964A5 true JP2022546964A5 (enExample) 2023-09-05

Family

ID=68108985

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513188A Ceased JP2022546964A (ja) 2019-08-28 2020-08-28 Pbp結合二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220281918A1 (enExample)
EP (1) EP4021922A1 (enExample)
JP (1) JP2022546964A (enExample)
CN (1) CN114829374B (enExample)
GB (1) GB201912320D0 (enExample)
WO (1) WO2021038232A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
GB202002706D0 (en) * 2020-02-26 2020-04-08 Bicycletx Ltd Pbp3 binding bicyclic peptide ligands
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头
CN116802190A (zh) * 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
NZ731185A (en) * 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
GB201706477D0 (en) * 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
WO2019002842A1 (en) * 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
WO2020084305A1 (en) * 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof

Similar Documents

Publication Publication Date Title
JP2023515567A5 (enExample)
JP2023514791A5 (enExample)
Juan et al. Interplay between peptidoglycan biology and virulence in Gram-negative pathogens
US6204279B1 (en) Peptidomimetic efflux pump inhibitors
Kumar et al. Molecular mechanisms of bacterial resistance to antimicrobial agents
US6114310A (en) Efflux pump inhibitors
Eijkelkamp et al. Manganese uptake and streptococcal virulence
JP2020527564A5 (enExample)
JP5207734B2 (ja) 細菌感染症を治療するためのダルババンシン組成物
US7829543B2 (en) Substituted polyamines as inhibitors of bacterial efflux pumps
JP2013539751A5 (enExample)
JP2023515567A (ja) Pbp3結合二環式ペプチドリガンド
TR201905233T4 (tr) Dirençli bakteriyel enfeksiyonların tedavisine yönelik kombinasyon tedavisi.
Schroll et al. Polyamines are essential for virulence in Salmonella enterica serovar Gallinarum despite evolutionary decay of polyamine biosynthesis genes
Conlon et al. Clinical applications of amphibian antimicrobial peptides
Chakraborty et al. Iron Uptake in Bacteria with Emphasis on E. coli and Pseudomonas
Zheng et al. The AdcR-regulated AdcA and AdcAII contribute additively to zinc acquisition and virulence in Streptococcus suis
Aborah et al. Multidrug resistance and major facilitator superfamily antimicrobial efflux pumps of the ESKAPEE pathogen Staphylococcus aureus
Morton et al. Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae
Lau et al. Environmental adaptability and stress tolerance of Laribacter hongkongensis: a genome-wide analysis
EP3598868B1 (en) New polyimino ketoaldehydes
Baranova et al. Antimicrobial drug efflux pumps in other gram-positive bacteria
JP2004526663A (ja) ノビスピリン抗菌ペプチド
Terver Antibiotic Resistance: Mechanisms, Epidemiology, and Contemporary Therapeutic Strategies—a Comprehensive Review
JP2020508297A5 (enExample)